Home/Filings/4/0001415889-24-012151
4//SEC Filing

Luptakova Katarina 4

Accession 0001415889-24-012151

CIK 0001840233other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 4:10 PM ET

Size

5.5 KB

Accession

0001415889-24-012151

Insider Transaction Report

Form 4
Period: 2024-05-01
Luptakova Katarina
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2024-05-01+59,33359,333 total
    Exercise: $1.08Exp: 2034-04-30Common Stock (59,333 underlying)
Footnotes (1)
  • [F1]The option award was granted on May 1, 2024 and shall vest on June 1, 2024 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until May 1, 2028.

Issuer

Xilio Therapeutics, Inc.

CIK 0001840233

Entity typeother

Related Parties

1
  • filerCIK 0001991149

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:10 PM ET
Size
5.5 KB